1. Home
  2. VREX vs KMDA Comparison

VREX vs KMDA Comparison

Compare VREX & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$11.97

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.48

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
KMDA
Founded
2016
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
488.6M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
VREX
KMDA
Price
$11.97
$8.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$16.67
$14.00
AVG Volume (30 Days)
202.1K
54.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
3.03%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
$13.94
Revenue Next Year
$3.88
$9.84
P/E Ratio
$232.40
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$6.35
52 Week High
$14.57
$9.35

Technical Indicators

Market Signals
Indicator
VREX
KMDA
Relative Strength Index (RSI) 61.43 51.98
Support Level $11.43 $8.38
Resistance Level $12.61 $8.88
Average True Range (ATR) 0.35 0.20
MACD 0.22 0.02
Stochastic Oscillator 89.06 85.71

Price Performance

Historical Comparison
VREX
KMDA

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: